Mechanical agents (also called passive substances) are generally thought to be the most effective for small amounts of bleeding and they create a barrier to stop blood flow and a surface that permits blood to clot more rapidly.
North America is the largest consumption region, with a more than 40% market share. Then Europe is the second largest consumption region with the market share of about 30%. J&J, Baxter, BD, Gelita, Pfizer, B Braun are the leaders of the global Medical Hemostatic Agents market, and they hold more than 65% market share. Medical Hemostatic Agents is widely used in Hospital, Surgical Centers and other field. The most proportion of Medical Hemostatic Agents is Hospital, and the sales proportion is about 65%. The classification of Medical Hemostatic Agents includes Gelation Hemostats, Combination Hemostats and Others Type. The proportion of Combination Hemostats and Gelation Hemostats in 2019 is more than 50%.
The global Medical Hemostatic Agents market was valued at US$ 3466.6 million in 2019 and is expected to reach US$ 4552.9 million by the end of 2026, growing at a CAGR of 5.4% during 2021-2026.
This report focuses on Medical Hemostatic Agents volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Medical Hemostatic Agents market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Medical Hemostatic Agents Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Gelation Hemostats
Combination Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
J&J
Baxter
BD
Gelita
Pfizer
B Braun
CSL Behring
Ferrosan Medical Devices
Advance Medical Solution
Medtronic
Z-Medica
Marine Polymer
Equimedical
CryoLife
North America is the largest consumption region, with a more than 40% market share. Then Europe is the second largest consumption region with the market share of about 30%. J&J, Baxter, BD, Gelita, Pfizer, B Braun are the leaders of the global Medical Hemostatic Agents market, and they hold more than 65% market share. Medical Hemostatic Agents is widely used in Hospital, Surgical Centers and other field. The most proportion of Medical Hemostatic Agents is Hospital, and the sales proportion is about 65%. The classification of Medical Hemostatic Agents includes Gelation Hemostats, Combination Hemostats and Others Type. The proportion of Combination Hemostats and Gelation Hemostats in 2019 is more than 50%.
The global Medical Hemostatic Agents market was valued at US$ 3466.6 million in 2019 and is expected to reach US$ 4552.9 million by the end of 2026, growing at a CAGR of 5.4% during 2021-2026.
This report focuses on Medical Hemostatic Agents volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Medical Hemostatic Agents market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Medical Hemostatic Agents Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Gelation Hemostats
Combination Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
J&J
Baxter
BD
Gelita
Pfizer
B Braun
CSL Behring
Ferrosan Medical Devices
Advance Medical Solution
Medtronic
Z-Medica
Marine Polymer
Equimedical
CryoLife
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.